OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
33 hedge funds and large institutions have $55.1M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
–
Holders Change %
0%
% of All Funds
0.57%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
4
Increased
8
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$212K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$118K |
| 3 |
JPMorgan Chase & Co
New York
|
+$88K |
| 4 |
Renaissance Technologies
New York
|
+$67K |
| 5 |
Morgan Stanley
New York
|
+$65.1K |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$99.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$88.6K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$83.9K |
| 4 |
Millennium Management
New York
|
-$74.3K |
| 5 |
NM
Newtyn Management
New York
|
-$56K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
State Street
Boston,
Massachusetts
| $55K | – | – | – |
|
|
BFM
27
Boothbay Fund Management
New York
| $53K | -$5.58K | -168 | -10% |
|
|
RC
28
RBF Capital
San Francisco,
California
| $49K | – | – | – |
|
29
Northern Trust
Chicago,
Illinois
| $40K | – | – | – |
|
30
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $37K | +$37K | +1,106 | New |
|
31
Citigroup
New York
| $25K | -$1.27K | -38 | -5% |
|
32
Wells Fargo
San Francisco,
California
| $4K | +$63 | +2 | +2% |
|
|
NM
33
Newtyn Management
New York
| – | -$56K | -2,098 | Closed |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$3K | -129 | Closed |
|